Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction

Yazar: Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J.
Yayımlandı Front Immunol (2021)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

Yazar: Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Yayımlandı Front Immunol (2017)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

Yazar: Rozenbaum, Meir, Meir, Amilia, Aharony, Yarden, Itzhaki, Orit, Schachter, Jacob, Bank, Ilan, Jacoby, Elad, Besser, Michal J.
Yayımlandı Front Immunol (2020)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex

Yazar: Greenberg, Eyal, Hajdu, Steven, Nemlich, Yael, Cohen, Ronit, Itzhaki, Orit, Jacob-Hirsch, Jasmine, Besser, Michal J., Schachter, Jacob, Markel, Gal
Baskı/Yayın Bilgisi 2014

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Yazar: Yunger, Sharon, Bar El, Assaf, Zeltzer, Li-at, Fridman, Eddie, Raviv, Gil, Laufer, Menachem, Schachter, Jacob, Markel, Gal, Itzhaki, Orit, Besser, Michal J
Yayımlandı Oncoimmunology (2019)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

Yazar: Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.
Yayımlandı J Immunother Cancer (2021)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions

Yazar: Baruch, Erez Nissim, Ortenberg, Rona, Avivi, Camila, Anafi, Liat, Dick-Necula, Daniela, Stossel, Chani, Moshkovits, Yonatan, Itzhaki, Orit, Besser, Michal Judith, Schachter, Jacob, Barshack, Iris, Markel, Gal
Yayımlandı Oncoimmunology (2020)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

Yazar: Itzhaki, Orit, Greenberg, Eyal, Shalmon, Bruria, Kubi, Adva, Treves, Avraham J., Shapira-Frommer, Ronnie, Avivi, Camilla, Ortenberg, Rona, Ben-Ami, Eytan, Schachter, Jacob, Besser, Michal J., Markel, Gal
Baskı/Yayın Bilgisi 2013

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

Yazar: Greenberg, Eyal, Hershkovitz, Liat, Itzhaki, Orit, Hajdu, Steven, Nemlich, Yael, Ortenberg, Rona, Gefen, Nir, Edry, Liat, Modai, Shira, Keisari, Yona, Besser, Michal J., Schachter, Jacob, Shomron, Noam, Markel, Gal
Baskı/Yayın Bilgisi 2011

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

Yazar: Galore-Haskel, Gilli, Nemlich, Yael, Greenberg, Eyal, Ashkenazi, Shira, Hakim, Motti, Itzhaki, Orit, Shoshani, Noa, Shapira-Fromer, Ronnie, Ben-Ami, Eytan, Ofek, Efrat, Anafi, Liat, Besser, Michal J., Schachter, Jacob, Markel, Gal
Yayımlandı Oncotarget (2015)

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

Yazar: Itzhaki, Orit, Jacoby, Elad, Nissani, Abraham, Levi, Michal, Nagler, Arnon, Kubi, Adva, Brezinger, Karin, Brayer, Hadar, Zeltzer, Li-at, Rozenbaum, Meir, Vernitsky, Helly, Markel, Gal, Toren, Amos, Avigdor, Abraham, Schachter, Jacob, Besser, Michal J
Yayımlandı J Immunother Cancer (2020)